No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database

Diabetic Medicine : a Journal of the British Diabetic Association
C R CardwellC C Patterson

Abstract

To determine whether children with infections in early life (recorded routinely in general practice) have a reduced risk of Type 1 diabetes, as would be expected from the hygiene hypothesis. Children with Type 1 diabetes and up to 20 matched (on year of birth, sex and region) control subjects were selected from a cohort of children born in the UK at General Practice Research Database practices. For each child, the frequency of general practitioner consultations for infections and prescriptions for antibiotics in the first year of life were determined. Odds ratios (ORs) and 95% confidence intervals (95%CIs) were calculated using conditional logistic regression. The main analysis included 367 case and 4579 matched control subjects. There was no evidence of any reduction in the subsequent risk of Type 1 diabetes in children with at least one infection in the first year of life (OR = 1.03, 95%CI 0.79, 1.34) or in children prescribed antibiotics in the first year of life (OR = 1.03, 95%CI 0.82, 1.29). Further analyses also revealed little evidence of a difference in subsequent risk of Type 1 diabetes after different types of infection in the first year of life (including gastrointestinal, conjunctivitis, otitis media and upper and l...Continue Reading

References

Feb 1, 1992·International Journal of Epidemiology·C C Patterson, N R Waugh
Sep 16, 1995·BMJ : British Medical Journal·S KinnA Millman
Jul 1, 1994·Diabetologia·H Kolb, R B Elliott
Mar 6, 1998·Archives of Disease in Childhood·C GibbonD Phillips
Apr 23, 1999·Lancet·T Walley, A Mantgani
Apr 28, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·P A McKinneyH J Bodansky
Apr 25, 2001·Diabetologia·A KupilaUNKNOWN Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland
Dec 4, 2001·Pediatrics·F DeStefanoUNKNOWN Vaccine Safety Datalink Team
May 29, 2002·Diabetologia·E A M Gale
Jan 21, 2004·Annals of Epidemiology·Sandra SipetićSlobodan Radmanović
Apr 9, 2004·The New England Journal of Medicine·Anders HviidMads Melbye
May 25, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·J GreenR Newton
Dec 22, 2006·American Journal of Epidemiology·E RomanUNKNOWN United Kingdom Childhood Cancer Study Investigators
Sep 14, 2007·Pediatric Diabetes·UNKNOWN TEDDY Study Group

❮ Previous
Next ❯

Citations

Oct 1, 2011·Database : the Journal of Biological Databases and Curation·Charles F TurnerPhilip C Cooley
Dec 15, 2010·International Journal of Epidemiology·Chris R CardwellChris C Patterson
Jun 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Remy H H BemelmansPeter E Spronk
Apr 16, 2011·Occupational Medicine·O O OgundipeB M Frier
Jul 10, 2013·BMC Gastroenterology·Karl MårildJonas F Ludvigsson
Apr 11, 2013·PloS One·Colin R MuirheadRichard J Q McNally
Mar 26, 2009·American Journal of Epidemiology·Anders Hviid, Henrik Svanström
Feb 3, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Danny Zipris
Jul 7, 2012·Pediatric Diabetes·Aushrat ShoshanGabriel Chodick
Jun 16, 2016·Lancet·Marian Rewers, Johnny Ludvigsson
Aug 13, 2014·Cancer Epidemiology·Gabor MezeiLeeka Kheifets
Oct 30, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Fraser W ScottJennifer A Crookshank
Feb 14, 2012·Chemico-biological Interactions·Joseph Wiemels
Sep 14, 2010·Cancer Epidemiology·Simon CrouchEve Roman
Feb 16, 2019·Water Science and Technology : a Journal of the International Association on Water Pollution Research·Ana B LanhamMaria A M Reis
Aug 27, 2013·Expert Review of Clinical Immunology·Alexia-Giovanna Abela, Stephen Fava
Jun 6, 2018·International Journal of Epidemiology·German TapiaLars C Stene
Dec 18, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Sonia ButaliaDoreen M Rabi
Sep 6, 2008·Current Opinion in Ophthalmology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.